Chengdu Easton Biopharmaceuticals Co., Ltd.SSE: 688513

Notice on Convening the 1st Extraordinary General Meeting in 2026

· Issued by Chengdu Easton Biopharmaceuticals Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 6 pages · Chinese

Summary by 6ix AI

Shareholders can participate through both on-site and online voting methods. The notice outlines registration procedures and important details for attendees.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Notice on Convening the 1st Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Chengdu Easton Biopharmaceuticals Co., Ltd. on 6ix

Earlier from Chengdu Easton Biopharmaceuticals

Later from Chengdu Easton Biopharmaceuticals

All Chengdu Easton Biopharmaceuticals news releases